Mission
The Global Coalition for Adaptive Research (GCAR) is a 501(c)(3) nonprofit organization that develops and sponsors Master Protocols and Adaptive Platform Trials. GCAR aims to modernize clinical trials for more efficient, less costly drug development, ultimately speeding up the process from lab discovery to patient treatment.
Basic Information
Founded in
2017
EIN
82-1199380
Total Assets
$59.58 million
UN Sustainable Development Goals Supported
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
At a Glance
GBM AGILE Overview
A global adaptive clinical trial aimed at accelerating the discovery of new treatments for glioblastoma patients.
REMAP-CAP / COVID Overview
A platform trial aimed at evaluating multiple treatments for COVID-19 patients worldwide.
Ovarian CanceRx Overview
An innovative clinical research effort to accelerate treatment development for ovarian cancer patients.
Impact Stats
Number of Collaborators
Clinical Trial Collaborations
Successful partnerships with diverse stakeholders, including biotech/pharma, health authorities, and clinical researchers.
Total Patient Participants
Patient Participation
Engagement of patients in ongoing and innovative clinical trials.
Adaptive Trials Launched
Adaptive Trials Implementation
Introduction of new adaptive trial designs to improve the efficiency of drug development.
MIP Score (Beta)
The MIP Score is in beta! We'd love any feedback you may have.
The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.
Overall Score
63
48
/100
Program Expense Ratio
91.26%
20
/20
Program Revenue Growth
-30.22%
2
/20
Leverage Ratio
0.3291
12
/20
Working Capital Ratio
1.346
12
/20
Fundraising Efficiency
0
2
/20
Latest Filing Data: Form 990
Fiscal Year:2023
Source:Source: Self-reported by organization
Financial Details
Revenue
| Category | Amount | Percentage |
|---|---|---|
| Contributions, Gifts, and Grants | 3.081M | 10.71% |
| Program Services | 23.96M | 83.27% |
| Investment Income | 1.733M | 6.02% |
| Sales of Non-Inventory Assets | 0 | 0.00% |
| Other Notable Sources | 0 | 0.00% |
| Total Revenue | 28.78M | 100.00% |
Related Nonprofits
Brain Inflammation Collaborative Inc.
Med Research
Brain ResearchApbd Research Foundation
Med Research
Brain ResearchTisch Multiple Sclerosis Research Center of New York Inc.
Med Research
Brain ResearchBroderick Brain Foundation
Med Research
Brain ResearchDr Marnie Rose Foundation Inc.
Med Research
Brain Research